Letrozole Chemical Structure (Letro.fig1)
Letrozole Tablet
Product Images NDC 63850-0025
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 63850-0025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Letrozolefig (Letro.fig2)
Letrozole Graph (Letro.fig3)
Letrozole Graph (Letro.fig4)
Letrozole Graph (Letro.fig5)
Letrozole Graph (Letro.fig6)
Letrozole Tablets 2.5 mg- Bottle Of 30 Container Label (Letro.fig7)
NDC 63850-0025-1 is a prescription drug used for treating breast cancer. The medication is available in the form of Letrozole Tablets, USP with each film-coated tablet containing Letrozole USP 2.5 mg. The packaging comes with 30 tablets and it is recommended to be dispensed in a tight container. The medicine must be stored at 25°C (77°F) and should be kept away from children. The manufacturing company of the drug is Natco Pharma Limited, located in India. Dosage details can be found in the package insert, and the medication is only available on prescription.*
Letrozole Tablets Bottle Of 1000s Label (Letro.fig8)
The text provides information about Letrozole tablets, USP. Each film-coated tablet contains Letrozole USP 2.5 mg. Dosage instructions can be found in the package insert. The tablets are supplied in a container and should be kept at 25°C. The manufacturer is Natco Pharma Limited based in India. The tablets are available in a pack of 1000 tablets. The label has a dimension of 84 x 27 mm with colors of Panton 561C and black.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
